Drug Trial Radar · NCT05979493
QL Block in Laparoscopic Myomectomy
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Aug 24, 2024
Primary completion
Jul 1, 2028
Study completion Jul 3, 2028
Sponsor
- Lead sponsor
- Joseph Findley MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
Conditions
- Postoperative Pain
- Fibroid Uterus
Interventions
BupivacainDrug
30cc IM injection in each quadratus lumborum muscle (60cc total).
SalineDrug
30cc IM injection in each quadratus lumborum muscle (60cc total).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time in minutes from first analgesic request as measured by medical chart reviewTime frame: Up to 24 hours
- Total number of doses of rescue analgesics given as measured by medical chart reviewTime frame: Up to 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospitals Ahuja Medical Center
Beachwood, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.